JNJ vs PFE
Johnson & Johnson and Pfizer Inc., side by side — 10 fiscal years reported in USD, drawn from SEC filings.
Most recent reported year
| Metric | JNJ | PFE |
|---|---|---|
| Revenue | $94.2B | $62.6B |
| Net income | $26.8B | $7.8B |
| Gross margin | 67.9% | 74.3% |
| Net margin | 28.5% | 12.5% |
| Return on equity | 35.0% | 8.9% |
| Diluted EPS | $11.03 | $1.36 |
| Dividend / share | $5.14 | $1.72 |
| Payout ratio | · | · |
| Free cash flow | $19.7B | $9.1B |
| Equity | · | $86.5B |
| Net debt / equity | 0.27× | 0.73× |
| Current ratio | 1.03× | 1.16× |
| Revenue CAGR 5y | 2.7% | 8.5% |
| Profit CAGR 5y | 12.7% | −3.2% |
JNJ bills 1.5× the revenue of PFE, and keeps more of each dollar of revenue as profit (28.5% against 12.5%).
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner. "·" marks a figure not available in our data.
10 years side by side
| Fiscal year | JNJ | PFE |
|---|---|---|
| FY2025 | $94.2B | $62.6B |
| FY2024 | $88.8B | $63.6B |
| FY2023 | $85.2B | $59.6B |
| FY2022 | $80.0B | $101.2B |
| FY2021 | $78.7B | $81.3B |
| FY2020 | $82.6B | $41.7B |
| FY2019 | $82.1B | $40.9B |
| FY2018 | $81.6B | $40.8B |
| FY2017 | $76.5B | $52.5B |
| FY2016 | $71.9B | $52.8B |
Bottom line
| Fiscal year | JNJ | PFE |
|---|---|---|
| FY2025 | $26.8B | $7.8B |
| FY2024 | $14.1B | $8.0B |
| FY2023 | $35.2B | $2.1B |
| FY2022 | $17.9B | $31.4B |
| FY2021 | $20.9B | $22.0B |
| FY2020 | $14.7B | $9.2B |
| FY2019 | $15.1B | $16.0B |
| FY2018 | $15.3B | $11.2B |
| FY2017 | $1.3B | $21.3B |
| FY2016 | $16.5B | $7.2B |
19 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2025 | +$31,614,000,000 | JNJ |
| FY2024 | +$25,194,000,000 | JNJ |
| FY2023 | +$25,606,000,000 | JNJ |
| FY2022 | −$21,185,000,000 | PFE |
| FY2021 | −$2,548,000,000 | PFE |
| FY2020 | +$40,933,000,000 | JNJ |
| FY2019 | +$41,154,000,000 | JNJ |
| FY2018 | +$40,756,000,000 | JNJ |
| FY2017 | +$23,904,000,000 | JNJ |
| FY2016 | +$19,066,000,000 | JNJ |
| FY2015 | +$21,223,000,000 | JNJ |
| FY2014 | +$24,726,000,000 | JNJ |
| FY2013 | +$19,728,000,000 | JNJ |
| FY2012 | +$12,567,000,000 | JNJ |
| FY2011 | +$3,995,000,000 | JNJ |
| FY2010 | −$3,578,000,000 | PFE |
| FY2009 | +$12,628,000,000 | JNJ |
| FY2008 | +$15,451,000,000 | JNJ |
| FY2007 | +$12,677,000,000 | JNJ |
The higher-revenue side has changed between JNJ and PFE over this period. The gap has widened since the earliest year compared.
19 of 19 comparable fiscal years — a year missing data on either side is not counted.
19 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2025 | +16.0 pp | JNJ |
| FY2024 | +3.2 pp | JNJ |
| FY2023 | +37.7 pp | JNJ |
| FY2022 | −8.6 pp | PFE |
| FY2021 | −0.6 pp | PFE |
| FY2020 | −4.3 pp | PFE |
| FY2019 | −20.8 pp | PFE |
| FY2018 | −8.7 pp | PFE |
| FY2017 | −38.9 pp | PFE |
| FY2016 | +9.3 pp | JNJ |
| FY2015 | +7.7 pp | JNJ |
| FY2014 | +3.5 pp | JNJ |
| FY2013 | −23.4 pp | PFE |
| FY2012 | −11.1 pp | PFE |
| FY2011 | −1.6 pp | PFE |
| FY2010 | +8.9 pp | JNJ |
| FY2009 | +2.3 pp | JNJ |
| FY2008 | +3.5 pp | JNJ |
| FY2007 | +0.4 pp | JNJ |
The higher net margin has changed hands between JNJ and PFE over this period.
19 of 19 comparable fiscal years — a year missing data on either side is not counted.
Standard deviation, each side
PFE's net margin has been more volatile than JNJ's over the 19 comparable fiscal years — 10.5 percentage points of standard deviation against 7.3.
19 of 19 comparable fiscal years — a year missing data on either side is not counted.
Year by year
The lead in net margin changed hands between JNJ and PFE over these 19 fiscal years — JNJ led in 10 and PFE in 9.
19 of 19 comparable fiscal years — a year missing data on either side is not counted.
Standard deviation, each side
PFE's return on equity has been more volatile than JNJ's over the 19 comparable fiscal years — 9.2 percentage points of standard deviation against 8.6.
19 of 19 comparable fiscal years — a year missing data on either side is not counted.
Year by year
The lead in return on equity changed hands between JNJ and PFE over these 19 fiscal years — JNJ led in 14 and PFE in 5.
19 of 19 comparable fiscal years — a year missing data on either side is not counted.